Alpha Tau Medical Ltd. (DRTS) Free cash flow 2019–2025
Alpha Tau Medical Ltd. (DRTS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$32.8MFY2025 · since FY2019: -$8.2M → -$32.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$32.8M | -48.7% |
| FY2024 | -$22.0M | +9.6% |
| FY2023 | -$24.4M | +1.7% |
| FY2022 | -$24.8M | -68.1% |
| FY2021 | -$14.7M | -33.8% |
| FY2020 | -$11.0M | -34.3% |
| FY2019 | -$8.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More DRTS financial trends
DRTS RevenueDRTS Net incomeDRTS Net marginDRTS Gross profitDRTS Gross marginDRTS Operating incomeDRTS Operating marginDRTS Operating cash flowDRTS Capital expendituresDRTS Return on equityDRTS Stock buybacksDRTS Dividends paidDRTS Total assetsDRTS Total liabilitiesDRTS Shareholders’ equityDRTS overview →